PATHOLOGY & ONCOLOGY RESEARCHVol. 2 No. 4, 1996

 Article

M-ESLON (retard release morphine sulphate capsules) for Pain Control in Cancer Patients

Attila J HORVÁTH, Anita SZABÓ, Tünde GÁSPÁR, Lajos BOGNÁR, Miklós TEKERES

Institute of Anaesthesiology and Intensive Therapy, University of Medicine, Pécs, Hungary

 

The pain of patients who were in the terminal phase of advanced malignant tumors was successfully relieved by M-ESLON capsules of controlled release morphine sulphate (10-30-60-100 mg). The most frequent side effects (sickness, vomiting, obstipation) were effectively controlled. The concentration of the drug in the plasma was stable, therefore the lasting pain relief was ensured. Pathology & Oncology Research, Vol 2, Nr 4, 242-243, 1996

Key words: cancer pain; morphine sulphate; controlled release; side effects


Received: Feb 10, 1996; accepted: Dec 20, 1996
Correspondence: Attila J HORVÁTH, Institute of Anaesthesiology and Intensive Therapy, University of Medicine, 13 Ifjúság Rd. Pécs H-7643, Hungary

Click here to get the full-text version in PDF!
ad